• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Vigil Neuroscience, Inc. - Common Stock (NQ:VIGL)

8.050 UNCHANGED
Last Price Updated: 4:00 PM EDT, Aug 4, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Vigil Neuroscience, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
The Biotech Renaissance: Innovation and M&A Frenzy Spark a Historic Year-End Rally
December 22, 2025
As the curtains draw on 2025, the biotechnology sector has emerged as the undisputed champion of the equity markets, staging a dramatic year-end rally that has caught even the most optimistic analysts... 
Via MarketMinute
Topics ETFs Economy Intellectual Property
News headline image
Loss-Making Russell 2000 Stocks Drive Surprise Rally, Says Liz Ann Sonders ↗
October 10, 2025
Liz Ann Sonders, the Chief Investment Strategist at Charles Schwab & Co. (NYSE: SCHW) highlighted certain unusual divergences in the small cap markets. 
Via Benzinga
News headline image
Eli Lilly's Early Alzheimer's Drug Recommended For Approval By European Drug Regulator's Panel ↗
July 25, 2025
Eli Lilly's donanemab gets CHMP backing for early Alzheimer's in select patients after trials show reduced disease progression and cognitive decline. 
Via Benzinga
News headline image
VIGIL NEUROSCIENCE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Vigil Neuroscience, Inc. - VIGL
July 14, 2025
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CHTR, TASK, VIGL, STRM on Behalf of Shareholders
July 03, 2025
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CRKN, ELEV, STR, VIGL on Behalf of Shareholders
June 13, 2025
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Crown Electrokinetics Corp. (OTC - CRKN), Elevation Oncology, Inc. (Nasdaq - ELEV), Sitio Royalties Corp. (NYSE - STR), Vigil Neuroscience, Inc. (Nasdaq - VIGL)
June 13, 2025
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Crown Electrokinetics Corp. (OTC - CRKN), Elevation Oncology, Inc. (Nasdaq - ELEV), Sitio Royalties Corp. (NYSE - STR), Vigil Neuroscience, Inc. (Nasdaq - VIGL)
June 09, 2025
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Flowserve Corporation (NYSE – FLS), Streamline Health Solutions, Inc. (Nasdaq – STRM), Sitio Royalties Corp. (NYSE – STR), Vigil Neuroscience, Inc. (Nasdaq – VIGL)
June 04, 2025
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates VIGL, STR, BPMC, STRM on Behalf of Shareholders
June 04, 2025
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Vigil Neuroscience Provides Update on Iluzanebart Phase 2 IGNITE Trial in ALSP
June 04, 2025
From Vigil Neuroscience, Inc.
Via GlobeNewswire
News headline image
Peraso Inc. (NASDAQ: PRSO) Aligned with BEAD Act’s $42.45B Broadband Mission: Driving Scalable Wireless Innovation
May 27, 2025
Via AB Newswire
Topics Artificial Intelligence
News headline image
Synergy CHC Corp. (NASDAQ: SNYR) Eyes Roth Capital’s Target Amid Profit Streak, Global Expansion & Sector Momentum
May 27, 2025
Via AB Newswire
Topics Artificial Intelligence
News headline image
On Tuesday, there are stocks with unusual volume. Let's take a look. ↗
May 27, 2025
Volume analysis on 2025-05-27: stocks with an unusual volume in today's session. 
Via Chartmill
News headline image
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates SGMA, VIGL, STRR on Behalf of Shareholders
May 24, 2025
From Halper Sadeh LLC
Via GlobeNewswire
News headline image
Which stocks have an unusual volume on Friday? ↗
May 23, 2025
Let's explore the current happenings on the US markets on Friday. Below, you'll find the stocks exhibiting unusual volume in today's session. 
Via Chartmill
News headline image
US Stocks Likely To Open On A Mixed Note: 'Nothing Good Happens Above A 5% Yield,' Says Expert ↗
May 23, 2025
U.S. stock futures were fluctuating on Friday after a mixed close on Thursday. Futures of benchmark indices were mixed in premarket. 
Via Benzinga
News headline image
Nasdaq Gains Over 50 Points Following Positive Economic Reports: Investor Sentiment Improves, Fear Index Remains In 'Greed' Zone ↗
May 23, 2025
 
Via Benzinga
News headline image
VIGIL NEUROSCIENCE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Vigil Neuroscience, Inc. - VIGL
May 22, 2025
From Kahn Swick & Foti, LLC
Via Business Wire
News headline image
Navitas (NASDAQ: NVTS) Surges on NVIDIA Deal – SNYR, VIGL, XAGE Lead $2 Stock Watch Now, More Inside
May 22, 2025
Via AB Newswire
Topics Artificial Intelligence
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
May 22, 2025
 
Via Benzinga
News headline image
Dow Moves Higher; US Initial Jobless Claims Fall ↗
May 22, 2025
 
Via Benzinga
Topics Stocks
News headline image
Nasdaq Gains Over 100 Points; BJ's Wholesale Earnings Top Views ↗
May 22, 2025
 
Via Benzinga
News headline image
Sanofi Inks A $470 Million Alzheimer's Deal, Sending This Dollar Stock Flying ↗
May 22, 2025
The company is working on an Alzheimer's treatment that increases the activity of TREM2, a neuroinflammation target. 
Via Investor's Business Daily
News headline image
Accenture To Rally More Than 24%? Here Are 10 Top Analyst Forecasts For Thursday ↗
May 22, 2025
 
Via Benzinga
News headline image
Vigil Neuroscience Stock Triples Pre-market On Acquisition By Sanofi: Retail Goes Super Bullish ↗
May 22, 2025
Under the terms of the deal, Sanofi will acquire all outstanding common shares of Vigil for $8 per share in cash at closing. 
Via Stocktwits
News headline image
Shareholder Alert: The Ademi Firm Investigates Whether Vigil Neuroscience Inc. Is Obtaining a Fair Price for Its Public Shareholders
May 22, 2025
From Ademi & Fruchter LLP
Via Business Wire
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
May 22, 2025
 
Via Benzinga
News headline image
This Guidewire Software Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday ↗
May 22, 2025
 
Via Benzinga
News headline image
Sanofi Boosts Alzheimer's Pipeline With Vigil Neuroscience Acquisition ↗
May 22, 2025
Sanofi (SNY) to acquire Vigil Neuroscience (VIGL) for $470 million in cash, plus potential $2 per share payout. Acquisition excludes monoclonal antibody program and is expected to be finalized in Q3... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap